Table 5.

Summary of treatment-related adverse events

	Group A KLOX-001 gel formulation	Group B KLOX LED light	Group C KLOX-001 gel formulation + KLOX LED light	Group D Standard treatment	All subjects
	n=8	n=8	n=8	n=8	n=32
	n (%)	n (%)	n (%)	n (%)	n (%)
Total numbers and percentages of subjects with TEAEs	5 (63)	2 (25)	6 (75)	4 (50)	17 (53)
Erythema	3 (38)	1 (13)	0 (0)	2 (25)	6 (19)
Brow edema	1 (13)	1 (13)	2 (25)	0 (0)	4 (13)
Eye lid edema	2 (25)	0 (0)	1 (13)	0 (0)	3 (9)

Abbreviation: LED, light-emitting diode; TEAEs, treatment emergent adverse events.